<?xml version="1.0" encoding="UTF-8"?>
<p id="Par9">CD is an optimized drug based on the structure from a classic antimalarial drug named quinine which is mainly used for malaria, parenteral amoebiasis, etc. CD has shown apparent efficacy in treating COVID-19 in adult clinical trials [
 <xref ref-type="bibr" rid="CR23">23</xref>]. CD is available in oral tablets and injections. CD tablets were recommended for oral administration in 18–65 years of infected adults at a dose of 0.5 g every time, twice daily [
 <xref ref-type="bibr" rid="CR1">1</xref>], for 7 days. For BW ≤ 50 kg patients, CD dosage needs to be decreased to 0.5 g, once daily, during 3–7 days after administration in later released file [
 <xref ref-type="bibr" rid="CR24">24</xref>]. There is no dosage recommendation of CD in COVID-19 children so far. Acute poisoning of CD is usually fatal with a dose of 50 mg/kg according to the instruction. A report regarded chloroquine concentration &gt; 25 μmol/L as a fatal predictor [
 <xref ref-type="bibr" rid="CR25">25</xref>]. Extreme caution should be followed while prescribing CD for children.
</p>
